Search Results - "Peredo, I"
-
1
Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact
Published in Cell death and differentiation (01-02-2016)“…Glioblastoma (GBM) is associated with poor prognosis despite aggressive surgical resection, chemotherapy, and radiation therapy. Unfortunately, this standard…”
Get full text
Journal Article -
2
Assessment of Psychological Well-being After AbobotulinumtoxinA Treatment: A Comparison of 2 Reconstitution Volumes
Published in Dermatologic surgery (01-02-2020)Get full text
Journal Article -
3
Clinical Assessment of 2 Licensed AbobotulinumtoxinA Injection Volumes for the Treatment of Glabellar Lines
Published in Dermatologic surgery (01-10-2019)“…BACKGROUNDTwo licensed reconstitution volumes may be used to achieve the recommended abobotulinumtoxinA (ABO) dose for glabellar line correction…”
Get full text
Journal Article -
4
Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu
Published in Journal of drugs in dermatology (01-06-2017)“…BACKGROUND: Acne vulgaris has varying physical and psychological effects in men and women of different ages, races, and ethnicities. OBJECTIVE: This analysis…”
Get more information
Journal Article -
5
Effects of valganciclovir as an add‐on therapy in patients with cytomegalovirus‐positive glioblastoma: A randomized, double‐blind, hypothesis‐generating study
Published in International journal of cancer (01-09-2013)“…Cytomegalovirus is highly prevalent in glioblastomas. In 2006, we initiated a randomized, double‐blind, placebo‐controlled, hypothesis‐generating study to…”
Get full text
Journal Article -
6
Valganciclovir in Patients with Glioblastoma REPLY
Published in The New England journal of medicine (21-11-2013)Get full text
Journal Article -
7
Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival
Published in Journal of clinical virology (01-05-2013)“…Abstract Background Patients with glioblastoma multiforme (GBM) generally live 12–15 months after diagnosis, despite maximal surgical resection, adjuvant…”
Get full text
Journal Article -
8
Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients
Published in Oncoimmunology (01-02-2016)“…Glioblastoma multiforme (GBM) is a highly malignant tumor with a poor outcome that is often positive for human cytomegalovirus (HCMV). GBM patients often have…”
Get full text
Journal Article -
9
Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma
Published in PloS one (31-03-2011)“…The presence of stem cell characteristics in glioma cells raises the possibility that mechanisms promoting the maintenance and self-renewal of tissue specific…”
Get full text
Journal Article -
10
Use of Cox regression with treatment status as a time‐dependent covariate to re‐analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir
Published in International journal of cancer (01-07-2014)Get full text
Journal Article -
11
Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
Published in Oncotarget (13-04-2018)“…Neoepitope-specific T-cell responses have been shown to induce durable clinical responses in patients with advanced cancers. We explored the recognition…”
Get full text
Journal Article -
12
Valganciclovir in Patients with Glioblastoma
Published in The New England journal of medicine (21-11-2013)“…To the Editor: Söderberg-Nauclér et al. (Sept. 5 issue) 1 report that cytomegalovirus (CMV) antigens are detected in more than 99% of human glioblastomas. In…”
Get full text
Journal Article -
13
NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma
Published in CANCER IMMUNOLOGY IMMUNOTHERAPY (01-02-2018)“…The prognosis for patients with glioblastoma is grim. Ex vivo expanded tumor-associated antigen (TAA)-reactive T-cells from patients with glioma may represent…”
Get full text
Journal Article -
14
Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
Published in Oncotarget (04-12-2018)“…[This corrects the article DOI: 10.18632/oncotarget.24955.]…”
Get full text
Journal Article -
15
Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma
Published in Oncotarget (06-10-2017)“…Glioblastoma multiforme (GBM) presents the most malignant form of glioma, with a 5-year survival rate below 3% despite standard therapy. Novel immune-based…”
Get full text
Journal Article -
16
Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery
Published in Oncoimmunology (01-01-2015)“…Patients with glioblastoma multiforme (GBM) are immunosuppressed and have a broad range of immunological defects in both innate and adaptive immune responses…”
Get full text
Journal Article -
17
Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV
Published in Oncoimmunology (01-02-2015)“…Background. Glioblastoma (GBM) is the most common malignant brain tumor in adults and is nearly always fatal. Emerging evidence suggests that human…”
Get full text
Journal Article -
18
Two-year survival of low-grade and high-grade glioma patients using data from the Swedish Cancer Registry
Published in Acta neurochirurgica (01-03-2011)“…Background Swedish health care legislation requires equal, high-quality health care for all inhabitants, while regional differences of medical availability and…”
Get full text
Journal Article -
19
Effects of valgancidovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study
Published in International journal of cancer (01-09-2013)“…Cytomegalovirus is highly prevalent in glioblastomas. In 2006, we initiated a randomized, double-blind, placebo-controlled, hypothesis-generating study to…”
Get full text
Journal Article -
20
Increased Survival Using Delayed Gamma Knife Radiosurgery for Recurrent High-Grade Glioma: A Feasibility Study
Published in World neurosurgery (01-11-2014)“…Objective The current study retrospectively assessed delayed gamma knife radiosurgery (GKRS) in the management of high-grade glioma recurrences. Methods A…”
Get full text
Journal Article